# The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

> **NCT05753839** · NA · RECRUITING · sponsor: **Yonsei University** · enrollment: 40 (estimated)

## Conditions studied

- Kidney Cancer
- Clear Cell Renal Cell Carcinoma Metastatic
- Synchronous Neoplasm

## Interventions

- **PROCEDURE:** Cytoreductive nephrectomy±metastasectomy
- **PROCEDURE:** Cytoreductive nephrectomy±metastasectomy
- **OTHER:** Human-derived materials sampling

## Key facts

- **NCT ID:** NCT05753839
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07
- **Primary completion:** 2027-12-27
- **Final completion:** 2031-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05753839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05753839, "The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05753839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*